Abstract
Objective: Because of the poor prognosis after treatment with surgery alone, high-risk endometrial cancer patients are usually treated with adjuvant therapy. However, prospective trial results have reported conflicting data, and little is known about current practice patterns. We surveyed gynecologic oncologists in the United States to determine their practice patterns and preferences for adjuvant therapy in women with high-risk endometrial cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
